Evidence map›Paper›PMID 33869985›Full record

ArticleJBMR plus2021

Silicon Oxynitrophosphide Nanoscale Coating Enhances Antioxidant Marker-Induced Angiogenesis During in vivo Cranial Bone-Defect Healing.

Felipe A do Monte, Neelam Ahuja, Kamal R Awad, Zui Pan, Simon Young, Harry Kw Kim, Pranesh Aswath, Marco Brotto, Venu G Varanasi

Open access · goldAbstract read
In one paragraph

Article in JBMR plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. SiONAntioxidants (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Journal of materials chemistry. B · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Wettability andSurface & coatings technology · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Felipe A do MonteDepartment of Bioengineering University of Texas at Arlington Arlington TX USA.
Neelam AhujaBone-Muscle Research Center University of Texas at Arlington Arlington TX USA.
Kamal R AwadBone-Muscle Research Center University of Texas at Arlington Arlington TX USA.
Zui PanBone-Muscle Research Center University of Texas at Arlington Arlington TX USA.
Simon YoungDepartment of Oral and Maxillofacial Surgery The University of Texas Health Science Center at Houston, School of Dentistry Houston TX USA.
Harry Kw KimCenter for Excellence in Hip Disorders Texas Scottish Rite Hospital Dallas TX USA.ORCID https://orcid.org/0000-0002-0330-4777
Pranesh AswathDepartment of Materials Science and Engineering University of Texas at Arlington Arlington TX USA.
Marco BrottoBone-Muscle Research Center University of Texas at Arlington Arlington TX USA.ORCID https://orcid.org/0000-0002-3199-9721
Venu G VaranasiBone-Muscle Research Center University of Texas at Arlington Arlington TX USA.ORCID https://orcid.org/0000-0002-9850-7824
The University of Texas at Arlington · USScottish Rite Hospital · USThe University of Texas Health Science Center at Houston · US

Funding

An Inverted Nikon A1R Laser Scanning Confocal MicroscopeS10OD025230 · OD · UNIVERSITY OF TEXAS ARLINGTON · PI PAN, ZUI · 2019 to 2019
$449k
Printing and Regenerating Fractured Bone Using Antioxidant MaterialsR56DE027964 · NIDCR · UNIVERSITY OF TEXAS ARLINGTON · PI VARANASI, VENU GOPAL · 2019 to 2019
$428k
Silicon, a Novel Antioxidant Role in Bone HealingR03DE023872 · NIDCR · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI VARANASI, VENU GOPAL · 2014 to 2015
$229k
NIDCR NIH HHS R03 DE023872NIDCR NIH HHS R56 DE027964NIH HHS S10 OD025230
6 · The paper itself

Abstract

Critical-sized bone defects are challenging to heal because of the sudden and large volume of lost bone. Fixative plates are often used to stabilize defects, yet oxidative stress and delayed angiogenesis are contributing factors to poor biocompatibility and delayed bone healing. This study tests the angiogenic and antioxidant properties of amorphous silicon oxynitrophosphide (SiONPx) nanoscale-coating material on endothelial cells to regenerate vascular tissue in vitro and in bone defects. in vitro studies evaluate the effect of silicon oxynitride (SiONx) and two different SiONPx compositions on human endothelial cells exposed to ROS (eg, hydrogen peroxide) that simulates oxidative stress conditions. in vivo studies using adult male Sprague Dawley rats (approximately 450 g) were performed to compare a bare plate, a SiONPx-coated implant plate, and a sham control group using a rat standard-sized calvarial defect. Results from this study showed that plates coated with SiONPx significantly reduced cell death, and enhanced vascular tubule formation and matrix deposition by upregulating angiogenic and antioxidant expression (eg, vascular endothelial growth factor A, angiopoetin-1, superoxide dismutase 1, nuclear factor erythroid 2-related factor 2, and catalase 1). Moreover, endothelial cell markers (CD31) showed a significant tubular structure in the SiONPx coating group compared with an empty and uncoated plate group. This reveals that atomic doping of phosphate into the nanoscale coating of SiONx produced markedly elevated levels of antioxidant and angiogenic markers that enhance vascular tissue regeneration. This study found that SiONPx or SiONx nanoscale-coated materials enhance antioxidant expression, angiogenic marker expression, and reduce ROS levels needed for accelerating vascular tissue regeneration. These results further suggest that SiONPx nanoscale coating could be a promising candidate for titanium plate for rapid and enhanced cranial bone-defect healing. © 2020 The Authors.

Indexed as

AMORPHOUS SILICON OXYNITROPHOSPHIDEANGIOGENESISANTIOXIDANTSBONE HEALINGOXIDATIVE STRESS

Identifiers

PMID33869985
PMCPMC8046063
OpenAlexW3093064323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.